You have 9 free searches left this month | for more free features.

City

Guangzhou (1)

Shantou (1)

Tianjin (1)

Condition

Metastatic Breast Cancer (1)

Small Cell Lung Cancer (1)

Overall Status

Not yet recruiting (1)

Unknown status (1)

Sign in for free

Phase

n/a (1)

phase 2 (1)

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1)

Tianjin Medical University Cancer Institute and Hospital (1)

Collaborator

Jiangsu HengRui Medicine Co., Ltd. (1)

Intervention

mecapegfilgrastim (2)

dalpiciclib (1)

exemestane, fulvestrant, letrozole, tamoxifen (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

mecapegfilgrastim

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Metastatic Breast Cancer Trial in Guangzhou, Shantou (Mecapegfilgrastim, dalpiciclib, exemestane, fulvestrant, letrozole,

Not yet recruiting

Metastatic Breast Cancer

Mecapegfilgrastim
+2 more

Guangzhou, Guangdong, China
+2 more

Jul 17, 2022

Small Cell Lung Cancer Trial in Tianjin (Mecapegfilgrastim)

Unknown status

Small Cell Lung Cancer

Mecapegfilgrastim

Tianjin, Tianjin, China

Tianjin Medical University Cancer Institute and Hospital

Nov 19, 2019